Method of making human cells expressing OCT4, SOX2, and Nanog using an Ecklonia cava extract
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 30, 2021
Grant Date -
Apr 27, 2017
app pub date -
Jun 25, 2014
filing date -
Jun 13, 2014
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present disclosure relates to a medium composition for r25/eprogramming induced pluripotent stem cells, containing an Ecklonia cava extract. Also, the present disclosure relates to a method for manufacturing induced pluripotent stem cells by using the medium composition. When the medium composition according to the present disclosure is used, induced pluripotent stem cells can be efficiently produced using adipose-derived mesenchymal stem cells safely and easily. The manufactured pluripotent stem cells are differentiable into various cells, and thus can be favorably used as a cell therapeutic agent.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully